10.01.09
Germany-based InterMed Discovery (IMD) has acquired unique microbial omega 3 fatty acid production strains and related know-how from the University of Saarland. The microbial strains are sustainable sources that generate reliably high yields of omega 3 fatty acids. This source also offers a favorable ratio between the fatty acids DHA and EPA, which the company believes will lead to the development of enhanced omega 3 formulations, thus paving the way for new product applications for the pharmaceutical, food and dietary supplement industries. IMD will lead the collaborative research and development project with the team at the University of Saarland.